Liver transplantation for treatment of hilar cholangiocarcinoma with a report of three Cases
10.3760/cma.j.issn.1673-4203.2018.06.006
- VernacularTitle:肝移植治疗肝门部胆管癌三例报道
- Author:
Xinghua HUANG
1
;
Yi JIANG
;
Huanzhang HU
;
Fang YANG
;
Qiucheng CAI
;
Jianyong LIU
;
Huaxiang WANG
;
Aiping WU
Author Information
1. 350025,解放军福州总医院肝胆外科
- Keywords:
Liver transplantation;
Bile duct neoplasms;
Hilar cholangiocarcinoma
- From:
International Journal of Surgery
2018;45(6):382-386
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the feasibility of liver transplantation in the treatment of inoperable hilar cholangiocarcinoma. Methods The clinical data for 3 patients with unresectable hilar cholangiocarcinoma who underwent liver transplantation in the Department of Hepatobiliary Surgery of Fuzhou General Hospital of People's Liberation Army from January 2006 to December 2012 were retrospectively analyzed. The patients were followed up by phone, outpatient service, and hospitalization. The starting point of the follow-up was the operation date. The patients death was the end point. The clinical and pathological features, postoperative survival, tumor recurrence, and prognostic factors were observed. The follow-up deadline was December 2017. Results All 3 patients underwent classical orthotopic liver transplantation using retrograde perfusion through inferior vena cava and no perioperative deaths occurred. All 3 patients were followed up for 10 to 132 months. During the follow-up period, of 1 patient who died of tumor recurrence, the pathological TNM stage was T4a N1 M0, and both had Union for International Cancer Control stage Ⅳa, and the tumor-free survival time was 3 months, and the survival time was12 months. Of 1 patient who died of other causes, the pathological TNM stage was T3N1 M0, and both had Union for International Cancer Control stage Ⅲ, and the tumor-free survival time was 12 months, and the survival time was12 months. One case as of the end of follow-up, the patient has survived for 132 months, the pathological TNM staging was T2a NOM0, and both had Union for International Cancer Control stage Ⅱ. Conclusions Lymph node positive and high pathological TNM stage were poor prognosis factor for hilar cholangiocarcinoma who underwent liver transplantation. Patients with early hilar cholangiocarcinoma who don't have lymph node metastasis are expected to benefit from liver transplantation.
